Table 5.

Neuropathologic damage of phase 2 experiments at 14 days after cardiac arrest

		Cardiac arrest
	Sham (n = 4)	6 min (n = 7)	8 min (n = 6)
		Advanced life support and adrenaline
Haematoxylin and eosin (counts of viable neurons)	58.75 ± 6.08	27.86 ± 14.70	16.67 ± 4.31
Fluoro-Jade (counts of dying neurons)	0.00 ± 0.00	45.14 ± 19.23	62.67 ± 9.14
Iba-1 immunostaining (semiquantitative–microglial activation)	0 (0–0)	3 (3–3)	3 (3–4)

Normally distributed values: mean ± SD; not normally distributed values: median (25–75th percentile).